Clinical Trial Inclusion and Exclusion Criteria: How to Know if You May Qualify

Andrea Enguita 3 Aug 2026

18 mins read

share this post

Couple assessing clinical trial inclusion and exclusion criteria

Introduction

If you are exploring clinical trials, one of the first questions you may have is: could I qualify?  

At first glance, clinical trial eligibility criteria can seem technical or overwhelming. They often include details about diagnosis, disease stage, previous treatments, lab values, and sometimes genetic markers. Understanding what these criteria mean can help you identify which clinical trials may be worth exploring and what to discuss next with your doctor or care team. 

It is also completely normal to feel uncertain when reading about clinical trials. Many patients are interested in exploring options but may not know whether a trial could be a good fit, what participation may involve or whether it is the right step for them.  

In this guide, we explain what clinical trial inclusion and exclusion criteria are, why they matter, and how to know if you may qualify for a clinical trial. This guide is intended as a starting point and does not replace a conversation with your doctor or healthcare team about whether a specific trial may be right for you. 

What are clinical trial eligibility criteria?

Clinical trial eligibility criteria are the rules that help determine whether a clinical trial may be a good fit for you based on your diagnosis, medical history, and other factors. While these criteria can seem complex, you do not need to interpret them on your own. They are typically reviewed through a pre-screening and screening process to confirm whether a trial may be suitable. 

Eligibility criteria include: 

These criteria may include factors such as: 

For example, a cancer trial might only include patients with a specific tumor type or genetic mutation. 

Why do clinical trials have eligibility criteria?

Eligibility criteria are an essential part of clinical trial design. They serve several important purposes, including: 

For example, some treatments that affect the immune system may carry additional risks for patients with certain autoimmune diseases. By carefully selecting participants, researchers can reduce potential risks. 

For instance, if a trial is studying a therapy designed to target a specific genetic mutation, it may only include patients who have that mutation. This helps researchers determine whether the treatment is effective for that group. 

What eligibility criteria often include

When you read a clinical trial listing, you will often see criteria about: 

What eligibility criteria mean for you as a patient

Reading and understanding clinical trial eligibility criteria can feel overwhelming, especially when the information is detailed or uses medical terminology. 

It is important to know that you do not need to fully understand or interpret every criterion on your own. In some cases, patient navigators and/or healthcare professionals can help review your situation and explain whether a clinical trial may be worth exploring. 

In most cases, your role is simply to identify whether a clinical trial may be broadly relevant based on factors such as your diagnosis, general health situation, or treatment history. The full assessment is typically carried out through medical review by the clinical trial team at the clinical trial location. 

Final eligibility decisions are not made by patients themselves, but by investigators and healthcare professionals who review your complete medical information in detail. 

Understanding whether to explore a clinical trial is not always a straightforward decision. It often involves balancing potential benefits, practical considerations, and personal circumstances. Taking part in a clinical trial can require more time and coordination than expected, including visits, follow-ups, and communication with the trial team.  

Important to know

Many patients worry they will automatically be excluded after reading eligibility criteria. In reality, eligibility is usually confirmed through a full medical review by the trial team, not just by scanning the list yourself. 

  • You do not need to fully understand every eligibility requirement on your own 
  • You do not need to decide whether you qualify before exploring a trial 
  • You are not expected to go through this process alone 
  • Even if a trial seems complex at first, it may still be worth exploring further 

 

How to read eligibility criteria in a clinical trial listing

If you want to get a general sense of whether a trial may be worth exploring, you can start by asking yourself a few simple questions. 

Good to know

If a trial seems relevant, but the criteria are unclear, it can help to speak with your doctor or another healthcare professional. They may be able to help you understand whether the clinical trial could be worth exploring.

 

Other factors to consider

Alongside the medical eligibility criteria, you may also want to think about a few practical considerations.  

Practical considerations can also include how often visits are required, and whether participation fits with your daily life, work, or caregiving responsibilities. These factors are not always part of the formal eligibility criteria, but they can still influence whether a clinical trial is a realistic option to explore. 

In some clinical trials, travel and participation support may be available. Depending on the trial and sponsor, this may include help arranging travel, lodging, meals, or local transportation. Some trials may use a travel concierge service or provide support in advance, such as a prepaid card or per diem for eligible expenses. In other cases, participants may need to submit expenses for reimbursement after travel. 

For international clinical trials, additional considerations may include cross-border travel, temporary relocation, and immigration requirements, such as obtaining a visa. Some related costs may be covered by the sponsor, while others may need to be paid out of pocket. 

Because support varies by clinical trial and location, it is important to ask what is covered, whether a caregiver or family member is included, and whether expenses are paid upfront or reimbursed later. 

If a clinical trial does not appear to be a fit or is not available, other pathways such as Expanded Access programs may sometimes be considered, depending on your situation and availability. 

Expanded Access, sometimes called compassionate use, is a way for patients with serious or life-threatening conditions to receive an investigational drug or treatment outside of a clinical trial when no other satisfactory treatment options are available and after the assessment by their doctor. 

What happens after you find a potentially relevant trial?

If a clinical trial appears to be a potential match, researchers need to confirm whether you meet the trial’s eligibility criteria. The next steps usually involve an initial review of your information (pre-screening), followed by a referral to a clinical trial location and a more detailed evaluation process (screening) to confirm eligibility.  

 

Confirming eligibility usually includes three steps: 

Confirming eligibility steps - 1. pre-screening 2. screening 3. eligibility confirmation

It is also important to keep your treating physician informed. They know your medical history, can help you understand whether a clinical trial may be worth discussing, and may support you as you consider your options. In some cases, they may also need to provide a referral, share relevant medical records, or confirm details about your diagnosis and treatment history. 

How myTomorrows can help you understand eligibility

Understanding clinical trial eligibility criteria can feel overwhelming, especially when they include complex medical terms, test requirements, and details about prior treatments.  

Support may be available to help you better understand what these criteria mean and whether a clinical trial may be worth exploring. At myTomorrows, patient navigators help review your situation, organize relevant medical information and identify clinical trials that may be aligned with your profile.  

The process typically follows a structured pathway 

This approach helps reduce uncertainty and ensures that both patients and clinical trial locations can focus on options that may be the most relevant. 

It is important to understand that myTomorrows does not decide whether a patient is eligible for a clinical trial and does not influence enrollment decisions. Final eligibility decisions are determined by the clinical trial investigators and doctors at the trial site. myTomorrows also does not provide medical advice or replace the role of your healthcare team. 

Key takeaways

Eligibility criteria can feel overwhelming at first, particularly if you are already dealing with a diagnosis or trying to compare different options. The good news is that you do not need to figure everything out on your own or understand every detail straight away. These are the main points to keep in mind as you review whether a clinical trial may be worth exploring. 

 

Frequently Asked Questions

Where can I find clinical trial eligibility criteria?

You can usually find clinical trial eligibility criteria on the page that describes the trial.  

These are often published on registries such as ClinicalTrials.gov, EudraCT or ISRCTN , hospital websites, or pharma websites. The eligibility criteria are often listed under headings such as “Eligibility,” “Inclusion Criteria,” or “Exclusion Criteria.”  

Keep in mind that these pages may use technical language, may not include every detail of the overall process, and can sometimes be difficult to compare or interpret. Platforms such as myTomorrows bring together clinical trial listings from multiple registries and help you explore and navigate potential options. 

Does meeting the eligibility criteria guarentee I will be enrolled?

No. Meeting the eligibility criteria does not automatically guarantee enrollment in a clinical trial.  

Even if you appear to match the published requirements, the trial team still needs to confirm eligibility through medical review and a formal screening process. Enrollment may also depend on practical factors such as whether the trial location is still recruiting, whether there are open spots available, and whether the clinical trial is accessible based on timing or location. Because clinical trials are designed to enroll a set number of participants, available spots may be limited, especially in some rare disease trials. In some cases, additional test results may also affect the final decision. The published criteria are an important starting point, but they are not a guarantee that you will be accepted. 

Who decides whether I’m eligible to join a clinical trial?

The clinical trial team at the trial location usually decides whether you are eligible, based on the trial’s eligibility criteria and a review of your medical information.  

 They assess whether the clinical trial is appropriate and safe for you and whether all trial requirements are met. In some cases, your doctor may also be involved. For example, they may need to provide medical records, confirm your diagnosis, or refer you to the clinical trial. Even when this is not required, speaking with your doctor about clinical trials can help you better understand whether a trial may be appropriate for your situation.  

Can clinical trial eligibility criteria change?

Yes, clinical trial eligibility criteria can change over time.  

Researchers may update them as they learn more about the treatment, gather additional safety information, or adjust the clinical trial design. In some cases, a trial may expand to include a broader group of participants. In others, criteria may become narrower if new risks or scientific considerations emerge.  

This means that a person who was not eligible at one point may become eligible later, or the reverse may also happen. If a trial once seemed out of reach, it may still be worth checking again later or asking the trial team whether anything has changed. 

Will my medical conditions exclude me from a clinical trial?

 It depends on the clinical trial.

Some medical conditions may exclude you from a trial if they could increase the risk of side effects or make it harder to understand whether the investigational treatment is working. Other conditions may be allowed, especially if they are well controlled or not directly related to what the trial is studying. 

Because every trial is different, the best way to know is to share your medical information with the trial team or your doctor so they can check the specific criteria and advise you.

What if I’m not sure whether I qualify?

It is common to be unsure, and you don’t need to figure this out on your own. 

Clinical trial eligibility criteria can be technical, detailed, and difficult to interpret without medical support. A good first step is to read the listing for the main points, such as diagnosis, age group, and prior treatment requirements. If the trial still seems potentially relevant, you can speak with your doctor, contact the trial team, or ask a Patient Navigator for help understanding the next steps. Even if you are uncertain, the trial may still be worth discussing. Final eligibility is usually confirmed through medical review. 

If a clinical trial does not appear to be a fit, other pathways, such as Expanded Access programs, may sometimes be considered depending on your situation and availability.

Why was I not eligible for a clinical trial?

There are several possible reasons why someone may not be eligible for a clinical trial.

These can include factors such as disease stage, previous treatments, lab results, or other medical conditions. In some cases, the trial may also have limited capacity or specific subgroup requirements. If you are not eligible for one trial, other clinical trials may still be available.

If you are not eligible for a clinical trial, other pathways may still be available in some cases. For example, Expanded Access programs may allow patients to access investigational treatments outside of a clinical trial under certain conditions.

What happens if a clinical trial is full?

If a clinical trial is full, it is no longer enrolling new participants.

This usually means that all available places in the study have been filled or that recruitment has paused. In some cases, additional groups (cohorts) may open later, or similar clinical trials may be available elsewhere. If a trial seems relevant but is full, it may still be worth exploring alternative options or checking again later.

In some cases, alternative pathways such as Expanded Access programs may also be considered.

What happens if I pass pre-screening for a clinical trial?

Passing pre-screening means that your information appears to match the main eligibility criteria at a high level.0

The next step is usually a referral to a clinical trial site, where the study team reviews your medical information in more detail. If appropriate, you may be invited to attend a screening visit, where tests and assessments are performed to confirm whether you meet all trial requirements.

How long does it take to find out if I am eligible for a clinical trial?

A patient navigator helps guide individuals through the process of exploring clinical trials.

They may support you in helpingassess eligibility criteria, organizing relevant medical information, identifying clinical trials that may be relevant to your situation, and helping you connect with trial sites.

Patient navigators do not make medical decisions or determine eligibility for a clinical trial. Their role is to support you in understanding the process and exploring potential options. 

 

Helpful resources

Getting started with clinical trials: 

 

Clinical trials by disease 

 

Understanding expanded access and compassionate use 

 

 

Our Patient Services

Our Patient Navigators are here to help you learn more about clinical trials and how they may be relevant to your specific situation 

If you’d like to speak with a Patient Navigator, you can book a (free) call at a time that suits you.

Book a free call with a Patient Navigator

 

 

About the author

Andrea Enguita Marruedo, PhD – Expert Medical Writer

Medical Content Writer at myTomorrows

Dr. Andrea Enguita Marruedo holds a master’s in Genetics and Cell Biology from the Autonomous University of Madrid and a PhD in Developmental Biology from the Erasmus Medical Centre in Rotterdam. She began her career in medical writing after completing her doctoral studies and has covered a wide range of therapeutic areas, including neuromuscular and neurodegenerative disorders, cancer, and diabetes.

Andrea specializes in translating complex biomedical topics into clear, accessible content for patients and healthcare professionals. With a strong research background and a passion for science communication, she is committed to delivering accurate, well-referenced content that supports greater awareness and understanding of medical topics among patients, caregivers, and clinicians.

share this post

Clinical TrialsEligibility criteria

Andrea Enguita 3 Aug 2026

more articles

view all blogs
Clinical Trials
AI
Research

The Referral Readiness Gap: What 100 U.S. Clinical Trial Sites Told Us About Referral Quality

Adrianne Rivard

14 Jul 2026

8 mins read

A man lying inside an MRI scanner while undergoing a brain scan.
Clinical Trials
Glioblastoma
Eligibility criteria

Glioblastoma Clinical Trial Eligibility: What Patients and Caregivers Should Know

Theo Cantero

29 Jun 2026

10 mins read

b.well & myTomorrows logos in partnership
Clinical Trials
AI
Patient Health Data

b.well Connected Health and myTomorrows Announce Partnership to Transform Clinical Trial Access for Patients

myTomorrows Team

26 May 2026

4 mins read

unifying data points
Clinical Trials
Patient Access
Data transparency

b.well x myTomorrows: Building Patient‑Centric Flows Across Care, Research, and Treatment

Dennis Akkaya

26 May 2026

8 mins read

Doctors discussing a clinical trial with patients
Clinical Trials
Treatment
Research

What is a Clinical Trial? How Clinical Trials Work

Andrea Enguita

20 May 2026

13 mins read

Clinical trial terms
Clinical Trials
Glossary

Clinical Trial Glossary: Key Terms and Definitions for Patients

Andrea Enguita

19 May 2026

37 mins read

Clinical Trials
Parkinson's disease
Patient Navigation

How to find and access a clinical trial for Parkinson’s disease: one person’s journey

Andrea Enguita

20 Apr 2026

12 mins read

Clinical Trials
Rare Disease

myTomorrows and Rare Disease Research Partner to Improve Access to Rare Disease Clinical Trials

myTomorrows Team

16 Apr 2026

4 mins read

myTomorrows CUN partnership logo lock up
Partnership
AI
Clinical Trial Recruitment

myTomorrows and Clínica Universidad de Navarra Partner to Advance AI-Powered Clinical Trial Infrastructure in Spain

myTomorrows Team

26 Mar 2026

5 mins read